Skip to content
Search

Latest Stories

GSK Consumer Healthcare launches carbon neutral Dr.BEST GreenClean toothbrush

GSK Consumer Healthcare (GSKCH) has launched its first carbon neutral Dr.BEST GreenClean toothbrush, raising sustainability standards in the oral care category.

Other popular brands of GSKCH, which is due to separate into a new company next year, include Sensodyne, parodontax, Voltaren and Advil.


With the new product, the company is striving to reduce the use of fossil fuels for virgin plastic.

The Dr.BEST GreenClean toothbrush handle is made from wood-based bioplastic that is derived from pine, spruce and birch trees in sustainable forests. It is a byproduct of paper production, and would otherwise be disposed of.

Its bristles are made of renewable castor oil, and its plastic free packaging includes GSKCH’s innovative cellulose window, which can easily be disposed of.

Besides, the firm has aligned with ClimatePartner, Europe’s leading solution provider for corporate climate action, to analyse and minimise the carbon impact of the product and its manufacturing.

The effort has reduced carbon footprint of the brush by over 50 per cent compared to the standard Dr.BEST toothbrush, and the remaining is offset through a community based ClimatePartner project in Madagascar.

Further, the company plans to apply this new technology across other toothbrushes in its portfolio - including its market leading Sensodyne brand.

A recent Nielsen study highlighted growing consumer preference for sustainable products noting that “73 per cent of consumers say they would definitely change their consumption habits to reduce their environmental impact.”

Gareth Rudduck, Oral Care sustainability lead, GSK Consumer Healthcare said: “We’re now collaborating with retailers and dental healthcare professionals to drive the growth of more sustainable options in oral care products across the world.

“Whilst this product achieves carbon neutral status by offsetting, we are working to develop future solutions that do not require offsetting. It’s just one part of our ongoing sustainability journey, in which we’re working to address the environmental and societal barriers to everyday health.”

GSKCH is on a mission to reduce the carbon it generates in line with the GSK’s commitment to achieve a net zero impact on climate by 2030, announced by CEO Emma Walmsley in November 2020.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less